News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Xiuning Le: Presented Dato-DXd with Osimertinib in EGFR-Refractory NSCLC Patients at ELCC25
Xiuning Le/X
Mar 29, 2025, 19:01

Xiuning Le: Presented Dato-DXd with Osimertinib in EGFR-Refractory NSCLC Patients at ELCC25

Xiuning Le, Associate Professor at MD Anderson Cancer Center, shared a post on X:

“A very successful ELCC25 I presented Dato-DXd (4mg/kg vs 6mg/kg) with osimertinib in EGFR refractory NSCLC patients, from ORCHARD trial. mPFS 11.7 mon and ORR 36% in Dato-DXd 6mg/kg cohort.

Improving upon what we have and explore new combinations. ”

Xiuning Le: Presented Dato-DXd with Osimertinib in EGFR-Refractory NSCLC Patients at ELCC25

More posts featuring ELCC25.

cancer ELCC25 Lung cancer NSCLC OncoDaily Oncology ORCHARD trial Xiuning Le
Special Coverage
Blog
Mar 30, 2025, 16:09
Hedley Lewis: No Family Should Face Childhood Cancer and Life-Threatening Blood Disorders Alone
Blog
Mar 30, 2025, 16:06
Anant Madabhushi: New Publication on AI-Driven Virtual Staining for Tumor-Associated Macrophages
Blog
Mar 30, 2025, 16:03
Research drives progress, and advocacy fuels change - Fight Colorectal Cancer
Blog
Mar 30, 2025, 15:52
St. Baldrick's Foundation - Honoring our heroes on National Doctors' Day
Blog
Mar 30, 2025, 15:48
Our experts are in Orlando for NCCN2025 - Roswell Park
Blog
Mar 30, 2025, 15:42
Peter Pisters: Honoring MD Anderson Cancer Center's Physicians on Doctors' Day for their commitment
Blog
Mar 30, 2025, 15:41
New NCI Funding Opportunity to New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes
Blog
Mar 30, 2025, 15:37
How PROs and CROs provide different but equally vital information - ESMO
Blog
Mar 30, 2025, 15:24
EORTC is Looking For a Medical Liaison Officer in Brussels
Blog
Mar 30, 2025, 15:14
Leandro Jonata Carvalho: Honored to participate in the 2025 LACOG-GBECAM Brazilian Breast Cancer Conference
Science
Mar 30, 2025, 15:09
Katsuaki Maehara: Genome doubling identified as a key factor in resistance for EGFRm lung cancer
Blog
Mar 30, 2025, 15:00
Jae Won Joh: Bill Gates Predicts AI Will Replace Doctors – But Who Takes on the Liability?